被误诊为两次或以上幽门螺杆菌根除失败的患者中自身免疫性胃炎高发
研究纳入2015年6月至2017年6月连续就诊于幽门螺杆菌门诊的404例患者,按根除史分为初治、单次失败和多次失败组。自身免疫性胃炎在多次失败组发生率为18.2%(40/220),显著高于初治组的1.5%(2/137)和单次失败组的2.1%(1/47)。作者认为自身免疫性胃炎患者因胃酸缺乏导致非幽门螺杆菌的产脲酶细菌定植,造成¹³C-UBT假阳性而被误诊为根除失败。
要点
- 多次根除失败组自身免疫性胃炎发生率为18.2%(40/220),显著高于初治组1.5%(2/137)和单次失败组2.1%(1/47)。
- 35例接受培养的自身免疫性胃炎患者中33例检出肺炎克雷伯菌、α-链球菌等产脲酶细菌。
- 自身免疫性胃炎患者可能因胃酸缺乏致非幽门螺杆菌产脲酶细菌定植,使¹³C-UBT呈假阳性。
核心结论
- 自身免疫性胃炎患者常被误诊为幽门螺杆菌根除治疗失败,可能因胃酸缺乏使非幽门螺杆菌的产脲酶细菌定植胃内,导致¹³C-UBT阳性。
研究设计与样本
- 研究纳入2015年6月至2017年6月连续就诊于本院幽门螺杆菌专病门诊的404例患者,其中初治137例、单次失败47例、两次或以上失败220例,均行胃镜检查。
- 对胃黏膜样本行幽门螺杆菌及其他产脲酶细菌培养,并检测抗壁细胞抗体(APCA)。
- 胃体严重萎缩且APCA阳性者诊断为自身免疫性胃炎。
主要发现
- 共43例诊断为自身免疫性胃炎,其中初治组2例(1.5%,2/137)、单次失败组1例(2.1%,1/47)、多次失败组40例(18.2%,40/220)。
- 自身免疫性胃炎发生率在多次失败组显著高于单次失败组或初治组。
- 35例接受培养的自身免疫性胃炎患者中33例检出肺炎克雷伯菌和α-链球菌等产脲酶细菌。
关键数值与推荐
- 自身免疫性胃炎诊断标准为胃体严重萎缩且APCA阳性。
- 根除失败次数以¹³C-UBT判定。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although autoimmune gastritis (AIG) is generally considered relatively rare, we frequently encounter AIG among patients at to our hospital who have experienced at least two episodes of Helicobacter pylori eradication failure. AIMS: We investigated the incidence of AIG in consecutive patients who consulted our department for H. pylori eradication with reference to eradication history. METHODS: A total of 404 consecutive patients who visited the H. pylori-specific out-patient unit of our hospital from June 2015 to June 2017 were enrolled. Of these, 137 were treatment-naive, 47 had failed treatment once (single failure), and 220 had failed treatment twice or more (multiple failures) by 13 C-UBT. Gastroscopy was performed in all patients. Culture tests of gastric mucosal samples were performed for H. pylori and other bacteria positive for urease activity. Anti-parietal cell antibody (APCA) was measured. Patients with severe atrophy in the gastric corpus and positivity for APCA were diagnosed as having AIG. RESULTS: A total of 43 patients were diagnosed as having AIG, of whom two were treatment-naive (1.5%, 2/137), 1 failed eradication once (2.1% 1/47), and 40 failed treatment at least twice (18.2%, 40/220). The incidence of AIG was significantly higher in the multiple failure group than in the single failure or treatment-naive groups. Urease-positive bacteria, such as Klebsiella pneumoniae and alpha-streptococcus, were identified in 33 of the 35 AIG patients who underwent culture testing. CONCLUSION: AIG patients were often misdiagnosed as refractory to eradication therapy, probably because achlorhydria in AIG might allow urease-positive bacteria other than H. pylori to colonise the stomach, causing positive 13 C-UBT results.
引用
- Furuta T, Baba S, Yamade M, et al. High incidence of autoimmune gastritis in patients misdiagnosed with two or more failures of H. pylori eradication. Aliment Pharmacol Ther. 2018. PMID: 29920721. doi:10.1111/apt.14849
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。